These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 9448842
1. Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies. Bonneau PR, Plouffe C, Pelletier A, Wernic D, Poupart MA. Anal Biochem; 1998 Jan 01; 255(1):59-65. PubMed ID: 9448842 [Abstract] [Full Text] [Related]
2. Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation. LaPlante SR, Aubry N, Bonneau PR, Cameron DR, Lagacé L, Massariol MJ, Montpetit H, Plouffe C, Kawai SH, Fulton BD, Chen Z, Ni F. Biochemistry; 1998 Jul 07; 37(27):9793-801. PubMed ID: 9657693 [Abstract] [Full Text] [Related]
3. A continuous fluorescence-based assay of human cytomegalovirus protease using a peptide substrate. Holskin BP, Bukhtiyarova M, Dunn BM, Baur P, de Chastonay J, Pennington MW. Anal Biochem; 1995 May 01; 227(1):148-55. PubMed ID: 7668375 [Abstract] [Full Text] [Related]
5. Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates. Gouvea IE, Izidoro MA, Judice WA, Cezari MH, Caliendo G, Santagada V, dos Santos CN, Queiroz MH, Juliano MA, Young PR, Fairlie DP, Juliano L. Arch Biochem Biophys; 2007 Jan 15; 457(2):187-96. PubMed ID: 17184724 [Abstract] [Full Text] [Related]
6. Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease. Konstantinidis AK, Richardson PL, Kurtz KA, Tripathi R, Chen CM, Huang P, Randolph J, Towne D, Donnelly J, Warrior U, Middleton T, Kati WM. Anal Biochem; 2007 Sep 15; 368(2):156-67. PubMed ID: 17644059 [Abstract] [Full Text] [Related]
7. Single-chain recombinant human cytomegalovirus protease. Activity against its natural protein substrate and fluorogenic peptide substrates. Pinko C, Margosiak SA, Vanderpool D, Gutowski JC, Condon B, Kan CC. J Biol Chem; 1995 Oct 06; 270(40):23634-40. PubMed ID: 7559530 [Abstract] [Full Text] [Related]
8. In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease. Stevens JT, Mapelli C, Tsao J, Hail M, O'Boyle D, Weinheimer SP, Diianni CL. Eur J Biochem; 1994 Dec 01; 226(2):361-7. PubMed ID: 8001553 [Abstract] [Full Text] [Related]
9. Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors. Bonneau PR, Grand-Maître C, Greenwood DJ, Lagacé L, LaPlante SR, Massariol MJ, Ogilvie WW, O'Meara JA, Kawai SH. Biochemistry; 1997 Oct 14; 36(41):12644-52. PubMed ID: 9376371 [Abstract] [Full Text] [Related]
10. Functional determinants of the Epstein-Barr virus protease. Buisson M, Valette E, Hernandez JF, Baudin F, Ebel C, Morand P, Seigneurin JM, Arlaud GJ, Ruigrok RW. J Mol Biol; 2001 Aug 03; 311(1):217-28. PubMed ID: 11469870 [Abstract] [Full Text] [Related]
11. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone. McCormack TA, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Plamondon L, Stein RL, Dick LR. Biochemistry; 1998 May 26; 37(21):7792-800. PubMed ID: 9601040 [Abstract] [Full Text] [Related]
13. A phosphotyrosine-containing quenched fluorogenic peptide as a novel substrate for protein tyrosine phosphatases. Nishikata M, Suzuki K, Yoshimura Y, Deyama Y, Matsumoto A. Biochem J; 1999 Oct 15; 343 Pt 2(Pt 2):385-91. PubMed ID: 10510304 [Abstract] [Full Text] [Related]
14. Development of in vitro peptide substrates for human rhinovirus-14 2A protease. Wang QM, Johnson RB, Sommergruber W, Shepherd TA. Arch Biochem Biophys; 1998 Aug 01; 356(1):12-8. PubMed ID: 9681985 [Abstract] [Full Text] [Related]
15. ADAM33 enzyme properties and substrate specificity. Zou J, Zhang R, Zhu F, Liu J, Madison V, Umland SP. Biochemistry; 2005 Mar 22; 44(11):4247-56. PubMed ID: 15766253 [Abstract] [Full Text] [Related]
16. Fluorogenic substrates for activated protein C: substrate structure-efficiency correlation. Butenas S, Drungilaite V, Mann KG. Anal Biochem; 1995 Mar 01; 225(2):231-41. PubMed ID: 7762785 [Abstract] [Full Text] [Related]
18. Fluorogenic peptides containing only alpha-amino acids. Wang W, Liang TC. Biochem Biophys Res Commun; 1994 Jun 15; 201(2):835-40. PubMed ID: 8003020 [Abstract] [Full Text] [Related]
19. [New donor-acceptor pairs for fluorogenic substrates with intramolecular fluorescence energy transfer for thrombin and trypsin]. Kholodovich VV, Kara DI, Gershkovich AA, Kibirev VK, Karabut LV, Klimenko IV, Korneliuk AI. Bioorg Khim; 1998 Mar 15; 24(3):179-85. PubMed ID: 9612559 [Abstract] [Full Text] [Related]
20. Cleavage specificity of human rhinovirus-2 2A protease for peptide substrates. Wang QM, Sommergruber W, Johnson RB. Biochem Biophys Res Commun; 1997 Jun 27; 235(3):562-6. PubMed ID: 9207196 [Abstract] [Full Text] [Related] Page: [Next] [New Search]